搜索筛选:
搜索耗时0.0944秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
类      型:
[期刊论文] 作者:Jean-Luc Raoul,Xavier Adhoute,, 来源:世界肝病学杂志:英文版(电子版) 年份:2016
Sorafenib is thus far the only systemic treatment for hepatocellular carcinoma(HCC) based on the results of two randomized controlled trials performed in Wester...
[期刊论文] 作者:Julien Edeline,Jean-Luc Raoul,, 来源:世界胃肠病学杂志:英文版(电子版) 年份:2009
瞄准:与没有肝硬化,发生在正常或 fibrotic 肝的 hepatocellular 癌(HCC ) 在病人的回顾的研究调查全身的化疗的功效和毒性。方法:有在正常或一个 fibrotic 肝的变形或局部地先...
[期刊论文] 作者:Jean-Luc Raoul,Xavier Adhoute,Marine Gilabert,Julien Edeline,, 来源:World Journal of Hepatology 年份:2016
Sorafenib is thus far the only systemic treatment for hepatocellular carcinoma(HCC) based on the results of two randomized controlled trials performed in Wester...
[期刊论文] 作者:Xavier Adhoute,Guillaume Pénaranda,Jean-Luc Raoul,Marc Bourlière,, 来源:World Journal of Hepatology 年份:2017
The Barcelona Clinic Liver Cancer classification is the most widely-used hepatocellular carcinoma(HCC) staging system because it is simple,precise and linked to...
[期刊论文] 作者:Julien Edeline,Jean-Luc Raoul,Elodie Vauleon,Anne Guillygomac'h,Karim Boud jema,Eveline Boucher,, 来源:World Journal of Gastroenterology 年份:2009
AIM:To investigate the efficacy and toxicity of systemic chemotherapy in a retrospective study of patients with hepatocellular carcinoma(HCC)occurring in normal...
相关搜索: